ロード中...
Comparison Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Incidence of Lung Cancer: A Retrospective Study
Introduction: Angiotensin-converting enzyme inhibitor (ACEI) and angiotensin II receptor blockers (ARBs) are taken as the first treatment option for hypertensive patients. The various global trials have suggested that ACEIs and ARBs may increase risk of lung cancer; however, the results are contradi...
保存先:
| 出版年: | Cureus |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cureus
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8168993/ https://ncbi.nlm.nih.gov/pubmed/34094750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.14788 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|